Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1535717 | 1.00 | F2 (0.47) | F2PRSS1PRSS2PRSS3CA14 | |
| SCHEMBL8359852 | 0.78 | HDAC6 (0.33) | — | |
| SCHEMBL16728067 | 0.76 | F2 (0.50) | F2PRSS1PRSS2PRSS3 | |
| SCHEMBL28416564 | 0.73 | HDAC6 (0.32) | — | |
| SCHEMBL2339827 | 0.72 | F2 (0.50) | F2PRSS1PRSS2PRSS3CA14 | |
| SCHEMBL2339824 | 0.72 | F2 (0.50) | F2PRSS1PRSS2PRSS3CA14 | |
| SCHEMBL12483135 | 0.72 | HDAC1 (0.31) | — | |
| SCHEMBL6813444 | 0.72 | HDAC1 (0.31) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL2352815 | 0.71 | CA14 (0.32) | F2PRSS1PRSS2PRSS3CA14 | |
| SCHEMBL15877146 | 0.71 | CA14 (0.30) | CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119019471-A | Fluorine-containing cytidine guanidine compound, and preparation method and application thereof | 沈阳农业大学 | 2024-11-26 | — | — | CN | claimed |
| CN-119019471-A | Fluorine-containing cytidine guanidine compound, and preparation method and application thereof | 沈阳农业大学 | 2024-11-26 | — | — | CN | disclosed |
| WO-2023209586-A1 | GLYCOMIMETIC BINDERS FOR L-SIGN | UNIVERSITÀ DEGLI STUDI DI MILANO (IT) | 2023-11-02 | — | — | WO | disclosed |
| EP-3830094-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | Mutabilis (FR) | 2021-06-09 | — | — | EP | disclosed |
| EP-3649146-A1 | APELIN PEPTIDES AND USES THEREOF | The Governors of the University of Alberta (CA) | 2020-05-13 | — | — | EP | disclosed |
| WO-2020025543-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | MUTABILIS (FR) | 2020-02-06 | — | — | WO | disclosed |
| WO-2019008438-A1 | APELIN PEPTIDES AND USES THEREOF | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2019-01-10 | — | — | WO | disclosed |
| EP-3352753-A1 | SYNTHETIC SPHINGOLIPID-LIKE MOLECULES, DRUGS, METHODS OF THEIR SYNTHESIS AND METHODS OF TREATMENT | The Regents of The University of California (US) | 2018-08-01 | — | — | EP | disclosed |
| EP-2751141-B1 | STABLE PEPTIDE-BASED PACE4 INHIBITORS | SOCPRA SCIENCES SANTE ET HUMAINES S E C (CA) | 2018-03-21 | — | — | EP | disclosed |
| US-9809621-B2 | Stable peptide-based PACE4 inhibitors | SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) | 2017-11-07 | — | — | US | disclosed |
| EP-1549670-B1 | TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIMICROBIAL ACTIVITY | POLYPHOR LTD (CH) | 2008-04-30 | — | — | EP | disclosed |
| EP-1855672-A1 | HIV PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2007-11-21 | — | — | EP | disclosed |
| US-20070054840-A1 | Template-fixed peptidomimetics with antimicrobial activity | POLYPHOR LTD. (CH) | 2007-03-08 | — | — | US | disclosed |
| US-20060280796-A1 | Inositol-based molecular transporters and processes for the preparation thereof | POSTECH FOUNDATION (KR) | 2006-12-14 | — | — | US | disclosed |
| WO-2006104646-A1 | HIV PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2006-10-05 | — | — | WO | disclosed |
| EP-1549670-A1 | TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIMICROBIAL ACTIVITY | Polyphor Ltd. (CH) | 2005-07-06 | — | — | EP | disclosed |
| WO-2004093821-A2 | TREATMENT OF ANTHRAX INFECTION USING INHIBITORS OF LETHAL FACTOR PROTEASE ACTIVITY | HAWAII BIOTECH, INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| WO-2004033489-A1 | TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIMICROBIAL ACTIVITY | POLYPHOR LTD. (CH) | 2004-04-22 | — | — | WO | disclosed |
| WO-2004009666-A2 | DENDRIMERS AS MOLECULAR TRANSLOCATORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-01-29 | — | — | WO | disclosed |
| WO-2003068807-A2 | ECHINOCANDIN CYCLIC PEPTIDE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060280796-A1 | Inositol-based molecular transporters and processes for the preparation thereof | SLC2A8, SLC2A1, SLC29A2 | F2 3907/4885PRSS1 4391/4885PRSS2 4826/4885 |
| US-20070054840-A1 | Template-fixed peptidomimetics with antimicrobial activity | POLL, CUTA, POLR1C | F2 951/4885PRSS1 750/4885PRSS2 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.